Sanford C. Bernstein restated their sell rating on shares of Monsanto Co. (NYSE:MON) in a research note issued to investors on Thursday.

Analyst Recommendations for Monsanto (NYSE:MON)

A number of other research analysts have also issued reports on MON. TheStreet upgraded Monsanto to a buy rating in a report on Thursday, May 26th. Deutsche Bank AG reaffirmed a buy rating and set a $100.00 price target on shares of Monsanto in a report on Wednesday, June 1st. Vetr downgraded Monsanto from a strong-buy rating to a buy rating and set a $117.33 price target for the company. in a report on Monday, May 30th. S&P Equity Research reaffirmed a positive rating on shares of Monsanto in a report on Thursday, September 15th. Finally, JPMorgan Chase & Co. reaffirmed a hold rating on shares of Monsanto in a report on Thursday, June 30th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $111.12.

Shares of Monsanto (NYSE:MON) opened at 102.88 on Thursday. The firm has a market capitalization of $45.02 billion, a price-to-earnings ratio of 45.28 and a beta of 1.24. The company’s 50-day moving average price is $105.86 and its 200 day moving average price is $100.40. Monsanto has a 12-month low of $81.22 and a 12-month high of $114.26.

Monsanto (NYSE:MON) last released its earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.40 by $0.23. The company earned $4.19 billion during the quarter, compared to analysts’ expectations of $4.49 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The company’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter last year, the business posted $2.39 earnings per share. On average, equities research analysts forecast that Monsanto will post $4.46 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is currently 89.26%.

In related news, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of the stock. Shell Asset Management Co. raised its stake in Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares during the last quarter. Legal & General Group Plc raised its position in shares of Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock worth $170,663,000 after buying an additional 46,878 shares in the last quarter. Hengehold Capital Management LLC acquired a new position in shares of Monsanto during the second quarter worth $224,000. Prudential Financial Inc. raised its position in shares of Monsanto by 10.8% in the second quarter. Prudential Financial Inc. now owns 619,028 shares of the company’s stock worth $64,014,000 after buying an additional 60,246 shares in the last quarter. Finally, Sigma Planning Corp raised its position in shares of Monsanto by 12.8% in the second quarter. Sigma Planning Corp now owns 2,678 shares of the company’s stock worth $277,000 after buying an additional 303 shares in the last quarter. 79.22% of the stock is currently owned by hedge funds and other institutional investors.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.